Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oliver Peoples Insider Profile
4 Followers
Oliver Peoples, President & CEO, Director at Yield10 Bioscience, holds 15.04K shares in Yield10 Bioscience (Ticker: YTENQ).
Oliver Peoples has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Oliver Peoples's holdings
Insider Roles
President & CEO, Director
Roles that Oliver Peoples holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 23, 2015 - Jun 23, 2016
Return:-80.70%
The most profitable trade made by Oliver Peoples
Oliver Peoples's Trading History
List of latest transactions for each holding click on a transaction to see Oliver Peoples's performance on stock
You May Also Like
Oliver Peoples insider profile FAQ
What is the percentage of profitable transactions made by Oliver Peoples?
The percentage of profitable transactions made by Oliver Peoples is ―.
What is the average return per transaction made by Oliver Peoples?
The average return per transaction made by Oliver Peoples is ―.
What stocks does Oliver Peoples hold?
Oliver Peoples holds: YTENQ stocks.
What was Oliver Peoples’s latest transaction?
Oliver Peoples latest transaction was an Uninformative Sell of $2.19K.
What was Oliver Peoples's most profitable transaction?
Oliver Peoples’s most profitable transaction was an Informative Buy of YTENQ stock on June 23, 2015. The return on the trade was -80.70%.
What is Oliver Peoples's role in Yield10 Bioscience?
Oliver Peoples's role in Yield10 Bioscience is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.